Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Thiosemicarbazones are an important class of synthetic organic compounds exhibiting promising biological activities, including antiviral, antibacterial, antitubercular, antiprotozoal, antimalarial, antifungal, enzyme inhibitory, and antitumor. Different α-(N)-heterocyclic thiosemicarbazones are potent inhibitors of ribonucleotide reductase enzyme that play a critical role in the DNA synthesis; moreover, some have been found 1000-fold more potent than the clinical drug hydroxyl urea.

Objective

Different coordination complexes have been assessed for their efficacy to target MDR and surpass side effects associated with platinum drugs. In this work, we have prepared and investigated the anticancer potential of new platinum compounds of 3- hydroxy-2-formylpyridine thiosemicarbazones.

Methods

Novel Pt(II) complexes were synthesized and characterized by elemental analyses, FT-IR, 1H-NMR, UV-visible spectroscopy, and mass spectrometry. The anticancer activity of the synthesized compounds against HeLa cells by MTT assay was assessed. Protein-fixed and ligand-flexible docking studies were carried out using the Lamarckian genetic algorithm and Autodock 4.2 software.

Results

The IC values of compounds and through MTT screening against HeLa cells were found to be 107.16 µM and 132.13 µM, respectively. The binding energy value for the complex [Pt(HyPyMe)Cl] was -6.49 kcal/mol. While for complex, [Pt(HyPyPyrd)Cl] was found to have a binding energy value of -6.83 kcal/mol.

Conclusion

The spectroscopic and analytical data showed the mononuclear structures and square planar geometry of the Pt(II) complexes. The compounds exhibited moderate antineoplastic activity, and N(4)-methyl-substituted compound exhibited better anticancer activity. [Pt(HyPyMe)Cl] complex formed hydrogen bond interactions with guanine-6, guanine-7 and thiamine-8. While, [Pt(HyPyPyrd)Cl] interacted with guanine-7 and guanine-16 hydrogen bond interaction.

© 2023 Bentham Science Publishers
© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cis/10.2174/2210299X01666220901114730
2023-01-25
2024-11-22

  • From This Site

    /content/journals/cis/10.2174/2210299X01666220901114730
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E010922208409.html?itemId=/content/journals/cis/10.2174/2210299X01666220901114730&mimeType=html&fmt=ahah

References

  1. WHO. International Agency for Research on Cancer.2018
     [Google Scholar]
  2. KostovaI. Platinum complexes as anticancer agents.Recent Patents Anticancer Drug Discov.20061112210.2174/15748920677524645818221023
     [Google Scholar]
  3. RemeshA. Toxicities of anticancer drugs and its management.Int. J. Basic Clin. Pharmacol.20121121210.5455/2319‑2003.ijbcp000812
     [Google Scholar]
  4. SiwekA. StączekP. WujecM. BielawskiK. BielawskaA. PanethP. Cytotoxic effect and molecular docking of 4-ethoxycarbonylmethyl-1-(piperidin-4-ylcarbonyl)-thiosemicarbazide—a novel topoisomerase II inhibitor.J. Mol. Model.20131931319132410.1007/s00894‑012‑1679‑623187686
     [Google Scholar]
  5. WeiL. EasmonJ. NagiR.K. MueggeB.D. MeyerL.A. LewisJ.S. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: Radiopharmaceuticals for PET of topoisomerase II expression in tumors.J. Nucl. Med.200647122034204117138747
     [Google Scholar]
  6. MishraV. PandeyaS.N. PannecouqueC. WitvrouwM. De ClercqE. Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (+/-)-3-menthone.Arch. Pharm. (Weinheim)2002335518318610.1002/1521‑4184(200205)335:5<183::AID‑ARDP183>3.0.CO;2‑U12210774
     [Google Scholar]
  7. ShakyaB. YadavP.N. Thiosemicarbazones as potent anticancer agents and their modes of action.Mini Rev. Med. Chem.202020863866110.2174/138955751966619102913031031660812
     [Google Scholar]
  8. ShakyaB. YadavP.N. UedaJ. AwaleS. Discovery of 2-pyridineformamide thiosemicarbazones as potent antiausterity agents.Bioorg. Med. Chem. Lett.201424245846110.1016/j.bmcl.2013.12.04424380769
     [Google Scholar]
  9. ShakyaB. ShahiN. AhmadF. YadavP.N. PokharelY.R. 2-Pyridineformamide N(4)-ring incorporated thiosemicarbazones inhibit MCF-7 cells by inhibiting JNK pathway.Bioorg. Med. Chem. Lett.201929131677168110.1016/j.bmcl.2019.04.03131053506
     [Google Scholar]
  10. EnyedyÉ.A. PrimikM.F. KowolC.R. ArionV.B. KissT. KepplerB.K. Interaction of Triapine and related thiosemicarbazones with iron(iii)/(ii) and gallium(iii): A comparative solution equilibrium study.Dalton Trans.201140225895590510.1039/c0dt01835j21523301
     [Google Scholar]
  11. AlomarK. LandreauA. AllainM. BouetG. LarcherG. Synthesis, structure and antifungal activity of thiophene-2,3-dicarboxaldehyde bis(thiosemicarbazone) and nickel(II), copper(II) and cadmium(II) complexes: Unsymmetrical coordination mode of nickel complex.J. Inorg. Biochem.2013126768310.1016/j.jinorgbio.2013.05.01323792913
     [Google Scholar]
  12. SerdaM. KalinowskiD.S. RaskoN. PotůčkováE. Mrozek-WilczkiewiczA. MusiolR. MałeckiJ.G. SajewiczM. RatusznaA. MuchowiczA. GołąbJ. ŠimůnekT. RichardsonD.R. PolanskiJ. Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: Dissection of critical structure-activity relationships.PLoS One2014910e11029110.1371/journal.pone.011029125329549
     [Google Scholar]
  13. FinchR.A. LiuM.C. CoryA.H. CoryJ.G. SartorelliA.C. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): An inhibitor of ribonucleotide reductase with antineoplastic activity.Adv. Enzyme Regul.199939131210.1016/S0065‑2571(98)00017‑X10470363
     [Google Scholar]
  14. NuttingC.M. van HerpenC.M.L. MiahA.B. BhideS.A. MachielsJ.P. ButerJ. KellyC. de RaucourtD. HarringtonK.J. Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma.Ann. Oncol.20092071275127910.1093/annonc/mdn77519246715
     [Google Scholar]
  15. ZeidnerJ.F. KarpJ.E. BlackfordA.L. SmithB.D. GojoI. GoreS.D. LevisM.J. CarrawayH.E. GreerJ.M. IvyS.P. PratzK.W. McDevittM.A. A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms.Haematologica201499467267810.3324/haematol.2013.09724624362550
     [Google Scholar]
  16. FrenchF.A. BlanzE.J.Jr The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.Cancer Res.1966268163816405923162
     [Google Scholar]
  17. FloreaA.M. BüsselbergD. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects.Cancers (Basel)2011311351137110.3390/cancers301135124212665
     [Google Scholar]
  18. LovejoyD.B. JanssonP.J. BrunkU.T. WongJ. PonkaP. RichardsonD.R. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.Cancer Res.201171175871588010.1158/0008‑5472.CAN‑11‑121821750178
     [Google Scholar]
  19. YadavP.N. BeveridgeR.E. BlayJ. BoydA.R. ChojnackaM.W. DeckenA. DeshpandeA.A. GardinerM.G. HambleyT.W. HughesM.J. JollyL. LavangieJ.A. MacInnisT.D. McFarlandS.A. NewE.J. GossageR.A. Platinum-oxazoline complexes as anti-cancer agents: Syntheses, characterisation and initial biological studies.MedChemComm20112427427710.1039/c0md00211a
     [Google Scholar]
  20. SharmaV. Piwnica-WormsD. Metal complexes for therapy and diagnosis of drug resistance.Chem. Rev.19999992545256010.1021/cr980429x11749491
     [Google Scholar]
  21. MehtaP.K. JoshiB. YadavP.N. Platinum (II) complex of 5-hydroxypyridine-2-carbaldehyde N(4)-ethylthiosemicarbazone: Synthesis, characterization and antineoplastic activity.J. Bangladesh Chem. Soc2015271&2132138
     [Google Scholar]
  22. ShahiN. PokhrelP. ThapaR.S. PokharelY. R. YadavP.N. Anticancer potency of 3-hydroxypyridine-2-carboxaldehyde N(4)-methyl and pyrrolidinylthiosemicarbazones and their Zn(II) complexes in PC3, HeLa, and DU145 cells through MTT assay and PI staining.Results Chem.20213100104
     [Google Scholar]
  23. HeinertD. MartellA.E. Pyridoxine and pyridoxal analogs. II. Infrared spectra and hydrogen bonding.J. Am. Chem. Soc.195981153933394310.1021/ja01524a031
     [Google Scholar]
  24. RogolinoD. CavazzoniA. GattiA. TegoniM. PelosiG. VerdolinoV. FumarolaC. CretellaD. PetroniniP.G. CarcelliM. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.Eur. J. Med. Chem.201712814015310.1016/j.ejmech.2017.01.03128182987
     [Google Scholar]
  25. DemertzisM.A. YadavP.N. Kovala-DemertziD. (II) complexes of the thiosemicarbazone and N-ethylthiosemicarbazone of 3-hydroxypyridine-2-carbaldehyde; Synthesis, properties and x-ray crystal structure.Helv. Chim. Acta20068991959197010.1002/hlca.200690187
     [Google Scholar]
  26. Karaküçük-İyidoğanA. TaşdemirD. Oruç-EmreE.E. BalzariniJ. Novel platinum(II) and palladium(II) complexes of thiosemicarbazones derived from 5-substitutedthiophene-2-carboxaldehydes and their antiviral and cytotoxic activities.Eur. J. Med. Chem.201146115616562410.1016/j.ejmech.2011.09.03121993152
     [Google Scholar]
  27. GambinoD. OteroL. VieitesM. BoianiM. GonzálezM. BaranE.J. CerecettoH. Vibrational spectra of palladium 5-nitrofuryl thiosemicarbazone complexes: Experimental and theoretical study.Spectrochim. Acta A Mol. Biomol. Spectrosc.200768234134810.1016/j.saa.2006.11.04317321785
     [Google Scholar]
  28. ElsayedS.A. El-HendawyA.M. MostafaS.I. Jean-ClaudeB.J. TodorovaM. ButlerI.S. Antineoplastic activity of new transition metal complexes of 6-methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-ray crystal structures of [VO2(mpETSC)] and [Pt(mpETSC)Cl].Bioinorg. Chem. Appl.20102010214914910.1155/2010/149149
     [Google Scholar]
  29. ReissA. MureseanuM. Transition metal complexes with ligand containing thioamide moiety: Synthesis, characterization and antibacterial activities.J. Chil. Chem. Soc.20125741409141410.4067/S0717‑97072012000400016
     [Google Scholar]
  30. BellC.F. MortimoreG.R. ReedG.L. The1H NMR spectra of zinc complexes of pyridine-2-carbaldehyde 2′-pyridylhydrazone.Org. Magn. Reson.197681454810.1002/mrc.1270080111
     [Google Scholar]
  31. SelbinJ. GutierrezM.A. Cyclometallation.J. Organomet. Chem.1981214225325910.1016/S0022‑328X(00)86634‑6
     [Google Scholar]
  32. YadavP.N. DemertzisM.A. Kovala-DemertziD. CastineirasA. WestD.X. Synthesis, solution and spectral studies of palladium(II) complexes with 2-hydroxyacetophenone N(3)-propylthiosemicar bazone. Crystal structure of a tripalladium complex.Inorg. Chim. Acta2002332120420910.1016/S0020‑1693(02)00710‑7
     [Google Scholar]
  33. HernándezW. CarrascoF. VaisbergA. SpodineE. ManzurJ. IckerM. KrautscheidH. BeyerL. Synthesis, spectroscopic characterization, structural studies, and in vitro antitumor activities of pyridine-3-carbaldehyde thiosemicarbazone derivatives.J. Chem20202020296016510.1155/2020/2960165
     [Google Scholar]
  34. AliA.Q. TeohS.G. SalhinA. EltayebN.E. AhamedM.B.K. MajidA.M.S.A. Synthesis of platinum(II) complexes of isatin thiosemicarbazones derivatives: In vitro anti-cancer and deoxyribose nucleic acid binding activities.Inorg. Chim. Acta201441623524410.1016/j.ica.2014.03.029
     [Google Scholar]
  35. FinkielszteinL.M. CastroE.F. FabiánL.E. MoltrasioG.Y. CamposR.H. CavallaroL.V. MoglioniA.G. New 1-indanone thiosemicarbazone derivatives active against BVDV.Eur. J. Med. Chem.20084381767177310.1016/j.ejmech.2007.10.02318063227
     [Google Scholar]
  36. VuD.B. DangT.B. SynthesizingN. (4)-substituted thiosemicarbazones and their structural characteristics.HCMUP J. Sci.201451219
     [Google Scholar]
  37. Kovala-DemertziD. DemertzisM. YadavP.N. CastiñeirasA. WestD.X. Preparation, spectral and structural characterization of (2-benzoylpyridine N(4)-methyl-N(4)-phenylthiosemicarbazonato) chloropalladium(II).Trans. Met. Chem. (Weinh.)199924664264710.1023/A:1006989117072
     [Google Scholar]
  38. QuangD.T. DoV.D. KinhC.D. UV-Vis spectra of some Platinum(II) complexes with thiosemicacbazonate ligands.Vietnam J. Chem.200543322325
     [Google Scholar]
  39. HernándezW. PazJ. VaisbergA. SpodineE. RichterR. BeyerL. Synthesis, characterization, and in vitro cytotoxic activities of benzaldehyde thiosemicarbazone derivatives and their palladium(II) and Platinum(II) complexes against various human tumor cell lines.Bioinorg. Chem. Appl.200820081910.1155/2008/690952
     [Google Scholar]
  40. AliA.A. NimirH. AktasC. HuchV. RauchU. SchäferK.H. VeithM. Organoplatinum (II) complexes with 2-acetylthiophene thiosemicarbazone: Synthesis, characterization, crystal structures, and in vitro antitumor activity.Organometallics20123162256226210.1021/om201178q
     [Google Scholar]
  41. MatesanzA.I. LeitaoI. SouzaP. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.J. Inorg. Biochem.2013125263110.1016/j.jinorgbio.2013.04.00523685347
     [Google Scholar]
  42. TyagiM. ChandraS. Synthesis, characterization and biocidal properties of platinum metal complexes derived from 2,6-diacetylpyridine (bis thiosemicarbazone).Open J. Inorg. Chem.201223414810.4236/ojic.2012.23007
     [Google Scholar]
  43. MatesanzA.I. SouzaP. Novel cyclopalladated and coordination palladium and platinum complexes derived from α-diphenyl ethanedione bis(thiosemicarbazones): Structural studies and cytotoxic activity against human A2780 and A2780cisR carcinoma cell lines.J. Inorg. Biochem.2007101101354136110.1016/j.jinorgbio.2007.05.01317640735
     [Google Scholar]
  44. ZhouJ. KangY. ChenL. WangH. LiuJ. ZengS. The drug-resistance mechanisms of five platinum-based antitumor agents.Front. pharmacol.20201111710.3389/fphar.2020.0034332265714
     [Google Scholar]
  45. NawazH. WaseemA. Zia-ur-Rehman NafeesM. ArshadM.N. RashidU. Synthesis, characterization, cytotoxicity and computational studies of new phosphine and carbodithioate based palladium(II) complexes.Appl. Organomet. Chem.20173111e377110.1002/aoc.3771
     [Google Scholar]
/content/journals/cis/10.2174/2210299X01666220901114730
Loading
Platinum(II) Complexes of 3-Hydroxypyridine-2-Carboxaldehyde, N(4)-Methyl and N(4)-Pyrrolidinyl Thiosemicarbazones: Synthesis, Characterization, and Primary Anticancer Screening against HeLa Cells, and Molecular Docking
Curr. Indian Sci. 1, e010922208409 (2023); https://doi.org/10.2174/2210299X01666220901114730
/content/journals/cis/10.2174/2210299X01666220901114730
/content/journals/cis/10.2174/2210299X01666220901114730
Loading

Data & Media loading...

Supplements

file format download Download

  • Article Type:     Research Article
Keyword(s): 3-hydroxypyridine; Antineoplastic activities; ESI-mass spectrometry; Molecular docking; Platinum(II) complexes; Thiosemicarbazone

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test